BTG said today it won FDA 510(k) clearance for its LC Bead Lumi radiopaque embolic beads designed for embolization of hypervascular tumors and arteriovenous malformations and touted results from the Renew study of its PneumRx endobronchial coil implant. The Lumi was designed with radiopacity tech that allows for real-time tracking of bead location during embolization procedures, London-based BTG […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
Boston Scientific recalls select Acuity guide catheters
Boston Scientific (NYSE:BSX) is recalling select lots of its 9Fr Acuity Pro coronary sinus outer guide catheters due to issues with the proximal handle separating from the shaft of the device. Boston Scientific named 16 different models in the recall, with 158 different lot numbers indicated. The recalled Acuity catheters are designed to provide pathways into […]
Edwards Lifesciences looks to mitral repair with Harpoon Medical stake
Edwards Lifesciences (NYSE:EW) took out a stake with an exclusive option to buy in Harpoon Medical potentially adding a mitral repair device to the mitral valve replacement being developed by recent acquisition CardiAQ Valve Technologies. Irvine, Calif.-based Edwards did not reveal the size of its stake in Harpoon when it released new guidance earlier this week. Harpoon, based […]
Edwards looks bullish on TAVR market as it releases 2016 guidance
Edwards Lifesciences (NYSE:EW) yesterday released financial strategies and guidance for the fiscal year 2016, raising expectations for the transcatheter heart valve market as a whole, as well as its stake in it over the coming years. The company upped its estimation for the global TAVR market opportunity to $5 billion by 2021. That number is up from […]
BioVentrix pulls in $14m in funding round, touts pre-clinicals
BioVentrix raised $14 million in a new round of equity funding and said it performed the 1st implantation of its micro-anchor Revivent device in a pre-clinical model. The Revivent treatment is a transcatheter-based procedure known as less invasive ventricular enhancement that reduces the overall size of the wall of the heart’s left ventricle, without the […]
UW to lead expansion of Medtronic’s HeartRescue program
Medtronic (NYSE:MDT) said today that the University of Washington will lead a U.S. expansion of its HeartRescue program, which aims to improve survival rates for sudden cardiac arrest. Fridley, Minn.-based Medtronic launched HeartRescue in 2010 in 5 states, looking to train healthcare providers on resuscitation methods to boost the SCA survival rate, which has not moved […]
Tissue Regeneration System, Materialise ink deal to print tracheal splints
Belgium-based additive manufacturer and 3D printing company Materialise said today it inked a deal with Tissue Regeneration Systems to create 3D-printed tracheal splints for use in clinical trials. Materialise said its Mimics Innovation Suite was used to design the stent, constructed from a bioresorbable platform licensed to TRS from the University of Michigan in 2007. […]
Patent board hands St. Jude Medical a win over patent troll
A U.S. patent board last week handed a win over a patent troll to St. Jude Medical (NYSE:STJ), ruling that several claims in a patent owned by Atlas IP LLC are unpatentable. Atlas, a so-called “non-practicing entity,” was pursuing infringement lawsuits against St. Jude, cross-town rival Medtronic (NYSE:MDT), Boston Scientific (NYSE:BSX) and Biotronik. In a Dec. 3 ruling, the U.S. Patent […]
EU OKs add’l delivery cath for InspireMD’s CGuard stent
InspireMD (OTC:NSPR) said Wednesday it won European Union regulatory approval, including CE Mark approval, for the manufacturing and commercialization of its CGuard stent delivery catheter. The approval also allows InspireMD to add-on manufacturing facilities for the device to enable more efficient work flow, the Boston-based company said. “We are pleased to receive Dekra certification for our […]
Report: TMVR at least 4 years from U.S. market
Transcatheter mitral valve replacements are at least 4 years out from hitting the U.S. market, despite the $2 billion recently dropped on companies developing the technology by some of the top names in medtech. Medtronic (NYSE:MDT), Abbott (NYSE:ABT), Edwards Lifesciences (NYSE:EW) and HeartWare International (NSDQ:HTWR) in recent months have spent a total of $2 billion to buy […]
Mitralign launches feasibility trial for Trialign tricuspid valve repair
Mitralign said today that it enrolled the 1st patient in the Scout feasibility trial of its Trialign tricuspid valve repair device under an investigational device exemption. The Tewksbury, Mass.-based company’s Trialign device is designed to use wire and catheters to implant polyester anchors within the annulus of the tricuspid valve, which separates the heart’s right atrium and right ventricle. The anchors […]